Trial Profile
A phase I/IIa trial of balugrastim in patients with breast cancer on myelosuppressive chemotherapy
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Balugrastim (Primary) ; Pegfilgrastim
- Indications Breast cancer
- Focus Adverse reactions; First in man
- 02 Sep 2015 New trial record